Find an expert

Dr. Andrés Gambini graduated with honors as a veterinarian at the University of Río Cuarto, Argentina, in 2008. After a period on an equine farm, he completed a Ph.D. program at the University of Buenos Aires (UBA) and taught in Animal Production Department. His Ph.D. focused on in vitro embryo production in horses. He produced the first cloned horses born in South America in 2010 and Australia in 2018. In 2015, he started a two years postdoc at the National Institute of Environmental Health Sciences (NIEHS) in the USA, where he investigated mechanisms governing embryonic genome activation in mammals. Andrés was invited as a professor at the University of Torino in Italy and the University of Cordoba in Spain. He continues his research in animal cloning, ICSI, and other reproductive biotechnologies. He recently reported the first cloned zebra embryos worldwide. He stood as Assistant Professor at the University of Buenos Aires, providing more than twelve years of lecturing, and mentoring undergraduate and postgraduate students in areas of animal physiology and reproduction. Currently, he is a senior lecturer in Animal Science, School of Agriculture and Food Sciences at University of Queensland, Australia.

Maher Gandhi received his medical degree in the UK in 1989, and then trained as a haematologist, including a Fellowship in malignant haematology at Princess Margaret Cancer Centre, Toronto. He was awarded a PhD in immunology at Cambridge University under Patrick Sissons. He moved to Brisbane and from 2003-2024 worked as a Senior Staff Specialist (Pre-Eminent Status) in the Haematology / Oncology Department of the Princess Alexandra Hospital. He leads his own laboratory group and has established an international reputation studying the tumour immune microenvironment in lymphoma and its manipulation, with continuous NHMRC/MRFF funding since 2005. He was Chair of Laboratory Sciences for the Australasian Leukaemia and Lymphoma Group between 2010-2016, won the prestigious Australian Society of Medical Research Clinical Research Award in 2010 and in 2012 took up the inaugural John McCaffrey Cancer Council of Queensland / Office of Health and Medical Research Clinical Research Fellowship. Between 2011-2014 he was privileged to serve as Chair of the Metro South Human Research Ethics Committee. In 2013 he was appointed Professor of Experimental Haematology, University of Queensland, based at the Translational Research Institute, in 2014 became the inaugural Leukaemia Foundation Chair of Blood Cancer Research at the University of Queensland Frazer Institute, and was appointed Cancer Program Head in 2016. In 2018 he became Executive Director and Director of Clinical Research at Mater Research. He also continues to head the Blood Cancer Research Group, which is based in Mater Research. In 2025 to current, he was appointed Chief Executive Officer of the Translational Research Institute and its manufacturing branch TM@TRI, to serve Queenslanders by transforming health through collaborative research.

Dr Elise Gane graduated with a Bachelor of Physiotherapy (Honours Class I) and a University Medal for academic achievement from The University of Queensland in 2008. She worked as a physiotherapist at the Princess Alexandra Hospital (2009-2013), a quaternary public hospital, treating complex patients across the continuum of care from Intensive Care and post-surgical wards to inpatient rehabilitation and outpatient services. In 2014, Elise commenced her PhD with The University of Queensland, focussed on measuring the musculoskeletal side effects at the neck and shoulder that result from neck dissection surgery for head and neck cancer. Following the awarding of her PhD in early 2018, Elise was employed as a post doctoral researcher at the RECOVER Injury Research Centre (UQ) exploring return to work and social roles after road traffic crash. Since January 2019, Elise has fulfilled the role of Physiotherapy Conjoint Research Fellow between the School of Health and Rehabiltiation Sciences (UQ) and the Princess Alexandra Hospital Physiotherapy Department. In this role, Elise mentors physiotherapists in health service-based research (both qualitative and quantitative) whilst also pursuing her own research interests, including a telehealth cancer exercise program. She teaches a research course in systematic review methodology to students in the Physiotherapy Graduate Entry Masters program.

Elise's areas of research interest include codesign, implementation science, allied health led-models of care, oncology rehabiltiation, lymphoedema, chronic disease, physical activity (particularly in rehabilitation settings, chronic disease, or the workplace), and musculoskeletal health.

My teaching practice is anchored in the scholarship of reflective practice, an evidence-based approach proven to enhance teaching quality and improve student outcomes and grounded in the conviction that quality teaching is fundamental to student success.

As the Academic Lead for Advancing Teaching at UQ’s Institute for Teaching and Learning Innovation (ITaLI), I design programs that enhance teaching excellence. Through these programs, my leadership and expertise impact governance, curriculum innovation, and has shaped inclusive academic communities within and beyond UQ.

My research impacts Higher Education globally and focuses on recognising and rewarding teaching expertise, shaping policies across higher education institutions. I have contributed to 24 curriculum reviews of academic programs, published 84 scholarly works, secured $1.9M in funding to investigate and innovate university education practices, and spearheaded international collaborations that influence teaching recognition and career progression globally.

A dedicated mentor, I have supported over 800 UQ staff in achieving HEA Fellowships, guided senior leaders globally in attaining their Principal Fellowship status. I have established similar schemes in partnership with 8 universities across in Australia, New Zealand, Hong Kong and the UK.

I am the program convener of the Graduate Certificate of University Teaching Practice which enables UQ staff develop teaching expertise. Successful completion of this accredited program leads to HEA Fellowship.

Professor Brenda Gannon is an international interdisciplinary leader providing evidence and solutions for health and social care systems, spanning across economics, medicine and social science, in collaboration with academia and industry. She brings extensive experience and expertise in program and policy development related to health and ageing, social inclusion, and citizen science, fostering and advancing excellence at the intersection of many disciplines.

Working at the interface of health service delivery, strategic planning and practice influence, and health economics more broadly, across many sectors, enables her research to inform optimisation of health care and workforce organisation. The models are translatable and transferrable across many sectors, including ageing, mental health, child and the working populations.

She is a Professor in the School of Economics and an Affiliate Professor at the Mater Research Institute, The University of Queensland. She is also an affiliate member of CEPAR (ARC Centre for Research Excellence in Population Ageing Research). Since 2022, she is Honorary Adjunct Professor at University of Galway, Ireland. She was Director of Research in the School of Economics from 2018-2023. . She has developed a range of projects on topics of dementia, physical activity and cognition, health and health care utilization, and consumer directed care and home care. She has led and worked extensively on interdisciplinary research with gerontologists,several clinicians and methodologists. Her work has been influential in the development of programs for falls preventions and informing policy on disability and social inclusion, and has positively impacted on the health of many older people across the world. Her work also spans across the lifecyle from birth, and she has worked with clinicians on trials for newborns with breathing difficulities. She is the Health Economics and Epidemiology lead for the Queensland Family Cohort (QFC) Study, the pilot led by Mater Research, and is on the QFC Governance Committee, focusing on maternal mental health, inequalities of opportunity, alcohol use and related health care use and costs.

Professor Gannon’s research carries a dual role, (1) as an applied health economist using big and complex data, utilising health economics theory and concepts to test the validity of causal hypotheses, (2) collaborator across all Faculties leading critical economic evaluations. Her research is funded by her position as chief investigator on projects from the Australian Research Council, National Health and Medical Research Council, MRFF, EU H2020, Health Research Board, Ireland and the National Institute for Health Research, UK. She is the lead economist on projects in dementia, emergency care and paediatric care. All studies incorporate methodological innovations and applied research. She has provided advice to government at senior levels, and had a Ministerial appointment, on the Medical Services Advisory Committee Evaluation Sub-Committee 2017-2021. She sits regularly as a panel member of various NHMRC and MRFF grant review committees and has also previously appointed to the EU Commission grant panels. She has been invited to give several talks at international fora, including a key note talk on ageing and longevity at the National Academy of Medicine, Global Roadmap to Healthy Longevity, in Washington DC. Professor Gannon was an elected Professorial member of the Academic Board at UQ 2018-2022. In 2023, Professor Gannon was elected a Fellow of the Queensland Academy of Arts and Sciences. She has been elected as a Council Member of Queensland Academy of Arts and Sciences since 2024. In 2023, she led a symposium on Economics of Dementia Care, with international colleagues, in collaboration with Dementia Australia.

Dr Mile Gao is a physicist specialising in condensed matter physics, with a focus on charge carrier dynamics in organic semiconductor devices. His research advances the development of novel measurement techniques to improve the understanding of organic light-emitting diodes (OLEDs) and organic photovoltaics (OPVs). He has pioneered several charge carrier mobility measurement methods, including Metal-Insulator-Semiconductor CELIV (MIS-CELIV), photo-MIS-CELIV, injection-CELIV, and photo-injection-CELIV. These techniques enable precise characterisation of charge transport and generation processes in diode-like structures, addressing key challenges in organic optoelectronics.

Dr. Mile's work has led to significant insights into charge injection, extraction, and mobility in organic semiconductors, with implications for improving device efficiency and stability. His research is highly interdisciplinary, combining physics, materials science, and device engineering.

He has published extensively in high-impact journals and holds a patent for his contributions to the field. As an ARC DECRA Fellow at The University of Queensland, he also teaches and supervises students in advanced experimental techniques for semiconductor characterisation.

Expertise:

• Charge transport in organic semiconductors
• Carrier generation efficiency in OPVs
• Advanced electrical characterisation techniques
• Organic optoelectronic device physics

Paul Gardiner's multidisciplinary research promotes active ageing with a focus on helping people improve and maintain quality of life. His PhD research reported for the first time that it is feasible to reduce sedentary time in older adults. His current research builds on this to examine behavioural approaches to dementia prevention.

He is part of the Our Voice Citizen Science global research network. This network has over 30 members across six continents and aims to improve health equity through allowing citizens to discover their environment, discuss their findings, and advocate for change.

He has a strong interest in diversity, equity and inclusion and co-founded the Equity, Diversity and Inclusion Special Interest Group of the Public Health Association of Australia (PHAA).

Previous research areas have included evaluation of drug and alcohol treatment services, development and dissemination of parenting programs, stillbirth epidemiology, and women's health.

Dr Kate Gartlan is an immunologist with considerable expertise in cellular immunology, particularly using in vivo models of inflammation to investigate immune-modulation and T cell polarisation. Dr Gartlan began her research career at WEHI within Professor Ken Shortman’s laboratory developing strong skills in both molecular and cell biology, where she became interested in the early factors that influence adaptive immunity. She completed her PhD in 2009 at the Burnet Institute working with Associate Professor Mark Wright, where she studied functional redundancy between Tetraspanin proteins in the immune system. To advance her understanding of inflammatory mediators and adaptive immune polarisation, she moved to the University of Oxford and took up a postdoctoral position within the Sir William Dunn School of Pathology. Working with Professor Quentin Sattentau, she investigated novel ways to modulate T cell polarisation and influence B cell responses to HIV vaccines.

After returning to Australia, she has worked with Professor Geoff Hill at QIMR Berghofer investigating novel therapies to treat graft-versus-host disease (GVHD) in allograft recipients. Dr Gartlan has held active teaching roles within both university and research institute environments, contributing to undergraduate science and medicine programs at both departmental and college levels.

Her main research interests at present surround the role of IL-17 & IL-22 in GVHD, potential therapeutics to modulate T cell polarisation after allogeneic bone marrow/stem cell transplant (BMT/SCT), as well as developing novel inhibitors of graft rejection to improve engraftment after BMT/SCT.

Professor Coral Gartner is an international expert in tobacco control policy and the world's leading expert on electronic nicotine delivery systems (or e-cigarettes). She is the Director of the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), an Australian Research Council Future Fellow, and the Chair of the Interdisciplinary Tobacco Endgame Research Network, the country lead Investigator for Australia with the International Tobacco Control Policy Evaluation Project (ITC Project), and a Co-Investigator with the SewAUs Wastewater Epidemiology Project. She is currently the Director of Research at the University of Queensland's School of Public Health, the Regional Editor for Australasia for the BMJ journal, Tobacco Control, after serving as a senior editor from 2012-2018. She is the immediate Past President of the Oceania Chapter of the Society for Research on Nicotine and Tobacco (SRNT-O).

She leads a multidisciplinary research team of international experts (located in Australia, New Zealand, Canada, the USA, England, and the Netherlands) to develop the evidence base for tobacco endgame strategies and to identify the most promising policies that could end the cigarette epidemic in Australia, and beyond. Her research program includes consideration of how these policies could be implemented, while mitigating potential unintended impacts and increasing equity. Her research methods span cohort studies, clinical trials, policy analyses, simulation modelling and mixed methods research.

Professor Gartner joined the University of Queensland in 2006. With undergraduate qualifications in environmental health and a PhD in environmental epidemiology, she completed a postdoctoral fellowship on tobacco control policy and held a NHMRC Career Development Fellowship (2014-2018). In 2019, she led the development of UQ’s flagship cross-faculty postgraduate programs in Environmental Health Sciences.

Professor Gartner has published over 300 academic works, including journal articles, book chapters, and submissions to government inquiries, and has served as an expert witness to a number of government inquiries and consultations. She has also authored articles on tobacco control topics for The Conversation.

Fleur Garton is a researcher focused on improving outcomes for those with a neurological disease. She completed a Bachelor of Applied Science (Hons I) in 2008 at the University of Sydney. Pursing an interest in the molecular basis of skeletal muscle function she completed her honours and PhD at the Institute of Neuroscience and Muscle research at the Children’s Hospital Westmead. Fleur spent two-years as post-doctoral researcher at the Murdoch Childrens Research Institute, Melbourne. She was responsible for modelling the effect of gene dosage using rAAV vectors while helping to contribute to studies on human performance and health. In 2016, Fleur moved to work with Professor Naomi Wray at the Program in Complex Trait Genomics team at the University of Queensland. She was awarded a Bill Gole MND Postdoctoral fellowship from MNDRA in 2016, an NHMRC Early Career Researcher Fellowship (2017-2022) and is now the Scott Sullivan MND Research Fellow (2022). Her research program aims to further understand the genetic mechanisms of motor neurone disease (MND/ALS) using novel genomics analyses. This includes investigations into the use of cell-free DNA and other 'omic data to improve diagnosis and treatment. Fleur currently has research projects running at the Royal Brisbane Womens Hospital and the Mater Hospital together with local and international collaborators. Any potential participants or collaborators are encouraged to contact her on email about these projects.

Professor Gail Garvey is a proud Kamilaroi woman, a NHMRC Research Leadership Fellow, and Professor of Indigenous Health Research in the Faculty of Medicine at the University of Queensland.

Professor Garvey has established an extensive and targeted research program focused on cancer and the wellbeing of Australia’s First Nations people.

Gail was among the first researchers to recognise the substantial impact of cancer on Aboriginal and Torres Strait Islander people, and her work has contributed greatly to key policy and practice changes to improve their cancer outcomes. Professor Garvey currently leads a Centre of Research Excellence – Targeted Approaches to Improve Cancer Services (TACTICS) for Aboriginal and Torres Strait Islander Australians (NHMRC #1153027 2019-2023). The TACTICS CRE focuses on emerging priorities in cancer-related health services research and actively promotes the translation of research knowledge into Australian public health policy and practice. The CRE also focuses on building research capacity through training the next generation of researchers in cancer control.

Gail leads work in psychosocial aspects of cancer care for First Nations Australians. Her research into the psychosocial aspects of cancer care for First Nations cancer patients, is a critical component to improving their cancer outcomes. Professor Garvey and her team developed and validated a new tool to measure the unmet support needs of Indigenous cancer patients, which is now a recommendation in the Optimal Care Pathway guidelines.

Professor Garvey's research program also focuses on understanding and measuring the dimensions of wellbeing important to and valued by Aboriginal and Torres Strait Islander people across the life course, which is important for developing/evaluating health interventions.

Originally trained as a teacher, Gail began her research career at the University of Newcastle in the 1990s where she was one of the first researchers to examine issues around the recruitment and retention of Aboriginal and Torres Strait Islander medical students. Since then she has been involved in a wide array of research collaborations both within Australia and overseas spanning three decades.

Along with her research expertise, Gail's strengths lie in her leadership and her collaborative approach to bringing key stakeholders - Indigenous consumers, researchers, and clinicians - together to achieve common goals. Career highlights include conducting the first Roundtable to identify research priorities in cancer for Indigenous Australians (2010); establishing the National Indigenous Cancer Network (2013) in collaboration with Cancer Council Australia, the Lowitja Institute, the Indigenous Health InfoNet and Menzies School of Health Research; instigating and convening the inaugural World Indigenous Cancer Conference in 2016 (Brisbane); and co-hosting the 2nd conference in 2019 (Canada).

Since 2011 Gail has received over $50 million in grant and government funding, including a NHMRC Investigator Leadership Grant (NHMRC #1176651 2020-2024). Over the same period Gail has published more than 180 papers in peer-reviewed.

Professor Nick Gaskell has had over 45 years' experience as a research active academic and, since retiring as a full-time academic, is currently Emeritus Professor of Maritime and Commercial Law at the TC Beirne School of Law. Previously, he held the posts of Dean of Law and Head of School (Acting), Director of the Marine and Shipping Law Unit, and Director of Research. Prior to joining the School he held (from 1994) the titled position of "David Jackson Professor of Maritime and Commercial Law" at the School of Law of the University of Southampton, UK. From 2003-2007 he was Head of that School, and from 1996-1999 was Director of its Institute of Maritime Law.

He has lectured widely to the maritime professions and academic community all over the world, including Belgium, China, Denmark, Finland, France, Germany, Greece, Holland, India, Italy, Japan, Korea, Malta, New Zealand, Norway, Pakistan, Poland, Singapore, South Africa, Sweden, Yugoslavia, UK. He first worked with the Maritime Law Association of Australia and New Zealand on courses in the 1980s and 1990s and continues to be an active member. He was a Visiting Law Lecturer at Monash University in 1984 and 1986. He has represented the International Union for the Conservation of Nature and Natural Resources (IUCN) at the International Maritime Organisation's Legal Committee, and at the meetings of the International Oil Pollution Compensation Funds. He attended and participated in many IMO meetings and diplomatic conferences which produced international maritime law conventions, including the Salvage Convention 1989, the 1992 Protocol to the Civil Liability Convention for Oil Pollution Damage, the Hazardous and Noxious Substances Convention 1996, the Bunker Pollution Convention 2001, the Athens Convention on the Carriage of Passengers 2002, the liability Protocol to the Antarctic Convention, and the Wreck Removal Convention 2007.

Professor Gaskell has written books and articles on a wide range of maritime and related commercial law subjects. He has most recently co-authored a book on The Law of Wreck. His work on carriage of goods by sea (bills of lading) has been cited in courts internationally, including Australia (High Court, Federal Court, Supreme Court of Victoria), Hong Kong, Singapore (Court of Appeal), New Zealand (High Court) and the UK (including the House of Lords). He is a Titulary Member of the Comite Maritime International (CMI), and is an Academic associate of Quadrant Chambers (a leading set of maritime law chambers in London).

Dr Jeff Gates's research interests are in: (a) Engineering failure analysis and forensic metallurgy; (b) Abrasive wear and wear-resistant alloys.

Dr Gates received his PhD from Monash University in 1985 and spent 15 years as an academic and senior researcher at the University of Queensland before starting UQ Materials Performance. He has been the Principal of UQMP (http://www.uqmp.com/) since its inception in 1998.

Dr Gates current long-term research projects are in the fields of:

• Development of white cast irons with improved abrasion resistance and fracture toughness
• Development of a suite of new-generation abrasive wear tests with verified predictive ability
• Development of methodologies for improving resistance to fatigue failure in machinery, including railway axles and conveyer drives
• Understanding the mechanical and metallurgical factors controlling the incidence of fires of electrical origin and other electrocutions

Will is a lecturer in Chinese translation within the University of Queensland’s Master of Arts in Chinese Translation and Interpreting programme and a practicing NAATI accredited professional translator. Having completed his BA (Hons) from the School of Oriental & African Studies (SOAS) in London, Will worked in Beijing at the British Embassy and then subsequently completed his PhD at the University of Queensland. In addition to Will’s teaching and research roles at UQ he is also a practicing commercial translator currently specialising in the translation of Chinese medical research into English.